Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Silva Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 3, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1,310	1,461	1,952	2,948	3,290	2,689
Market Cap Growth	0%	-25.17%	-33.80%	-10.37%	22.34%	7.65%
Enterprise Value	1,231	1,362	1,820	2,813	3,132	2,480
Last Close Price	9.60	10.70	14.16	21.29	23.42	18.63
PE Ratio	-	-	-	89.14	32.17	22.44
PS Ratio	3.67	3.81	3.26	4.11	4.22	3.36
PB Ratio	0.64	0.69	0.87	1.26	1.42	1.18
P/TBV Ratio	0.64	0.69	0.87	1.26	1.42	1.19
P/FCF Ratio	393.26	225.07	-	-	-	32.71
P/OCF Ratio	157.46	107.73	570.94	42.06	20.45	16.87
EV/Sales Ratio	3.45	3.55	3.04	3.92	4.02	3.10
EV/EBITDA Ratio	-	-	172.70	26.22	17.96	11.96
EV/EBIT Ratio	-	-	-	62.82	28.02	17.45
EV/FCF Ratio	369.39	209.82	-	-	-	30.16
Debt / Equity Ratio	0.02	0.02	0.02	0.03	0.04	0.02
Debt / EBITDA Ratio	-	-	4.29	0.56	0.55	0.20
Debt / FCF Ratio	9.61	4.87	-	-	-	0.52
Net Debt / Equity Ratio	-0.04	-0.03	-0.03	-0.05	-0.07	-0.10
Net Debt / EBITDA Ratio	1.04	1.13	-7.13	-1.11	-0.93	-1.10
Net Debt / FCF Ratio	-23.88	-10.97	2.54	7.15	9.67	-2.77
Asset Turnover	0.16	0.16	0.24	0.28	0.31	0.33
Inventory Turnover	0.61	0.61	0.89	1.00	1.04	1.07
Quick Ratio	5.10	5.97	5.17	5.11	3.76	6.13
Current Ratio	12.55	14.90	12.67	11.61	7.70	12.15
Return on Equity (ROE)	-6.88%	-6.09%	-2.81%	1.42%	4.45%	5.36%
Return on Assets (ROA)	-3.63%	-3.24%	-1.23%	1.11%	2.80%	3.62%
Return on Invested Capital (ROIC)	-6.68%	-5.73%	-2.20%	1.34%	4.66%	5.56%
Return on Capital Employed (ROCE)	-6.20%	-5.50%	-2.10%	1.90%	4.60%	6.00%
Earnings Yield	-11.10%	-9.10%	-3.30%	1.12%	3.11%	4.46%
FCF Yield	0.25%	0.44%	-1.52%	-0.57%	-0.51%	3.06%
Dividend Yield	-	-	0.71%	0.47%	1.28%	2.68%
Payout Ratio	-	-	-	75.66%	46.70%	39.46%
Total Shareholder Return	-	-	0.71%	0.47%	1.28%	2.68%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.